Clin Mol Hepatol > Accepted Articles
Correspondence on Letter regarding “Personalized Approaches to the Treatment of Hepatocellular Carcinoma Using Immune Checkpoint Inhibitors”
Sun Young Yim1, Sung Hwan Lee2, Ji Hoon Kim1, Sunyoung S Lee3, Ahmed O Kaseb3, Ju-Seog Lee4
1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, CHA Bundang Medical Center, CHA University, Korea
3Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
4Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Correspondence :  Ju-Seog Lee ,
Email: jlee@mdanderson.org
Received: September 23, 2024  Revised: September 29, 2024   Accepted: October 2, 2024

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2415
TOTAL : 2172450
Close layer